ozempic goodrx - Search News

Order byBest matchMost fresh

Novo Nordisk, Ozempic and GoodRx

Novo Nordisk, GoodRx selling Ozempic at half cost for customers paying cash

“Demand for GLP-1 medications is at an all-time high, but too many Americans still face barriers accessing them,” GoodRx CEO and President Wendy Barnes said in a statement.

· 3d · on MSN

Novo Nordisk Adds Ozempic to Direct-to-Consumer Offerings, at $499 Per Month. Why GoodRx Stock Spikes.

· 3d · on MSN

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers

· 1d

Novo Nordisk to present Wegovy® and Ozempic® data showing life-saving cardiovascular benefits for people living with obesity and type 2 diabetes at the European Society of Cardiology Congress 2025

“At the ESC congress, we are presenting new data substantiating the unique range of benefits semaglutide has on people with heart and kidney disease, as demonstrated in both clinical trials and in the...

· 2d

Canada approves Ozempic to cut risk of kidney failure, heart-related deaths

· 2d

Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval

Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets

GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible self-paying patients for $499-per-month through GoodRx,

Stock Movers: Novo Nordisk, GoodRX, CVS

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

BioSpace3d

Novo Teams Up With GoodRx for Lower-Price GLP-1s, Giving DTC Another Shot

Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip insurance. This is not the first time Novo has partnered with a pharmacy to offer the blockbuster drugs.